Norges Bank Akebia Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$2.92 - $5.06 $1.18 Million - $2.05 Million	-405,178 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$2.22 - $3.78 $899,495 - $1.53 Million	405,178 New	405,178 $1.13 Million
Q4 2020 Feb 10, 2021	SELL	$2.22 - $3.78 $1.81 Million - $3.08 Million	-814,284 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$2.39 - $13.08 $1.95 Million - $10.7 Million	814,284 New	814,284 $2.04 Million
Q3 2020 Nov 10, 2020	SELL	$2.39 - $13.08 $2.32 Million - $12.7 Million	-970,031 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$6.67 - $13.58 $6.47 Million - $13.2 Million	970,031 New	970,031 $13.2 Million
Q2 2020 Aug 07, 2020	SELL	$6.67 - $13.58 $6.14 Million - $12.5 Million	-920,031 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$4.1 - $10.24 $3.77 Million - $9.42 Million	920,031 New	920,031 $6.97 Million
Q1 2020 May 08, 2020	SELL	$4.1 - $10.24 $3.77 Million - $9.42 Million	-920,031 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$3.16 - $6.73 $2.91 Million - $6.19 Million	920,031 New	920,031 $5.82 Million
Q4 2019 Feb 12, 2020	SELL	$3.16 - $6.73 $2.91 Million - $6.19 Million	-920,031 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$3.55 - $5.4 $3.27 Million - $4.97 Million	920,031 New	920,031 $3.61 Million
Q3 2019 Nov 08, 2019	SELL	$3.55 - $5.4 $3.27 Million - $4.97 Million	-920,031 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$4.1 - $8.05 $3.77 Million - $7.41 Million	920,031 New	920,031 $4.45 Million
Q2 2019 Aug 09, 2019	SELL	$4.1 - $8.05 $4.43 Million - $8.7 Million	-1,081,061 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$5.41 - $8.73 $2.43 Million - $3.92 Million	448,602 Added 70.93%	1,081,061 $8.85 Million
Q4 2018 Mar 04, 2019	BUY	$5.39 - $9.15 $3.41 Million - $5.79 Million	632,459 New	632,459 $3.5 Million
Q2 2018 Jul 23, 2018	SELL	$9.15 - $11.34 $1.9 Million - $2.35 Million	-207,173 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$9.53 - $15.68 $1.97 Million - $3.25 Million	207,173 New	207,173 $1.97 Million
Q1 2018 May 09, 2018	SELL	$9.53 - $15.68 $4.35 Million - $7.16 Million	-456,573 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$14.24 - $19.59 $6.5 Million - $8.94 Million	456,573 New	456,573 $6.79 Million
Q4 2017 Feb 09, 2018	SELL	$14.24 - $19.59 $7.07 Million - $9.72 Million	-496,406 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$13.06 - $19.67 $6.48 Million - $9.76 Million	496,406 New	496,406 $9.76 Million
Q3 2017 Nov 07, 2017	SELL	$13.06 - $19.67 $1.31 Million - $1.97 Million	-100,000 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	100,000	100,000 $1.44 Million

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$20.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$17.7 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.1 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$8.37 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$6.54 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account